In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients

被引:0
|
作者
Tomasz Olszak
Paulina Zarnowiec
Wieslaw Kaca
Katarzyna Danis-Wlodarczyk
Daria Augustyniak
Pavel Drevinek
Anthony de Soyza
Siobhán McClean
Zuzanna Drulis-Kawa
机构
[1] University of Wroclaw,Institute of Genetics and Microbiology
[2] The Jan Kochanowski University,Division of Gene Technology
[3] Catholic University of Leuven,Department of Medical Microbiology, University Hospital Motol and 2nd Faculty of Medicine
[4] Charles University,Institute of Cellular Medicine, Medical School
[5] Newcastle University,Centre of Microbial Host Interactions
[6] Institute of Technology Tallaght,undefined
来源
关键词
bacteriophages; Phage treatment; Cystic fibrosis; model;
D O I
暂无
中图分类号
学科分类号
摘要
The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations.
引用
收藏
页码:6021 / 6033
页数:12
相关论文
共 50 条
  • [41] GENETIC-HETEROGENEITY IN STRAINS OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    OGLE, JW
    VASIL, ML
    JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (03) : 663 - 664
  • [42] MUCOID CONVERSION BY PHAGES OF PSEUDOMONAS-AERUGINOSA STRAINS FROM PATIENTS WITH CYSTIC-FIBROSIS
    MILLER, RV
    RUBERO, VJR
    JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (05) : 717 - 719
  • [43] Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis - clinical application
    Petrova, Guergana
    Perenovska, Penka
    Lesichkova, Spaska
    Lazova, Snezhina
    Miteva, Dimitrinka
    Cholakova, Kristina
    Strateva, Tanya
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    Döring, G
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) : 458 - 461
  • [45] CONVERSION OF PSEUDOMONAS-AERUGINOSA TO THE PHENOTYPE CHARACTERISTIC OF STRAINS FROM PATIENTS WITH CYSTIC-FIBROSIS
    SPEERT, DP
    FARMER, SW
    CAMPBELL, ME
    MUSSER, JM
    SELANDER, RK
    KUO, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (02) : 188 - 194
  • [46] RAPD-PCR characterization of Pseudomonas aeruginosa strains obtained from cystic fibrosis patients
    Ortiz-Herrera, M
    Gerónimo-Gailegos, A
    Cuevas-Schacht, F
    Pérez-Fernández, L
    Corio-Jiménez, R
    SALUD PUBLICA DE MEXICO, 2004, 46 (02): : 149 - 157
  • [47] Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada
    Beaudoin, Trevor
    Aaron, Shawn D.
    Giesbrecht-Lewis, Tracy
    Vandemheen, Kathy
    Mah, Thien-Fah
    CANADIAN JOURNAL OF MICROBIOLOGY, 2010, 56 (07) : 548 - 557
  • [48] ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF STRAINS OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    OJEDAVARGAS, MM
    BAQUERO, F
    MONZONMORENO, C
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 314 - 315
  • [49] In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients
    Aimee M. Dassner
    Christina Sutherland
    Jennifer Girotto
    David P. Nicolau
    Infectious Diseases and Therapy, 2017, 6 : 129 - 136
  • [50] Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients
    King, Paula
    Citron, Diane M.
    Griffith, David C.
    Lomovskaya, Olga
    Dudley, Michael N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 66 (02) : 181 - 186